Literature DB >> 1946851

Left-sided Parkinson's disease is associated with greater anxiety and depression.

S Fleminger1.   

Abstract

Seventeen patients with Parkinson's disease which was markedly asymmetric and worse on the right side of the body (RHP) were compared with 13 patients whose signs were worse on the left (LHP). The two groups of patients were well matched for age, duration of symptoms, disability, overall severity of signs, and medication. The mean scores on ratings of depression, using both a self-rating scale and semi-structured interview rating, were almost twice as great in the LHP group. The LHP group also had significantly more symptoms of anxiety. The prevalence of clinically significant psychopathology was increased about five fold in the LHP group compared with the RHP group. There was a close correlation between anxiety and depressive symptoms. The depression experienced by the patients was 'atypical', with relatively little anhedonia and evidence of a negative view of self, and prominent symptoms of anxiety. The best predictor of symptoms of depression and anxiety was a measure of social support and stress. They also correlated with the overall severity of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1946851     DOI: 10.1017/s0033291700022261

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  16 in total

Review 1.  The role of dopamine agonists in the treatment of depression in patients with Parkinson's disease: a systematic review.

Authors:  Albert F G Leentjens
Journal:  Drugs       Date:  2011-02-12       Impact factor: 9.546

2.  Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study.

Authors:  Daniela Di Giuda; Giovanni Camardese; Anna Rita Bentivoglio; Fabrizio Cocciolillo; Arianna Guidubaldi; Lorella Pucci; Isabella Bruno; Luigi Janiri; Alessandro Giordano; Alfonso Fasano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-09-14       Impact factor: 9.236

Review 3.  Depression in Patients with Parkinson's Disease: Current Understanding of its Neurobiology and Implications for Treatment.

Authors:  Stéphane Prange; Hélène Klinger; Chloé Laurencin; Teodor Danaila; Stéphane Thobois
Journal:  Drugs Aging       Date:  2022-06-16       Impact factor: 4.271

4.  Motor symptoms at onset of Parkinson disease and risk for cognitive impairment and depression.

Authors:  Richard B Dewey; Aanchal Taneja; Shawn M McClintock; C Munro Cullum; Richard B Dewey; Ira Bernstein; Mustafa M Husain
Journal:  Cogn Behav Neurol       Date:  2012-09       Impact factor: 1.600

Review 5.  Parkinson's disease and anxiety.

Authors:  K Walsh; G Bennett
Journal:  Postgrad Med J       Date:  2001-02       Impact factor: 2.401

Review 6.  The neuropsychology of depression: a literature review and preliminary model.

Authors:  Brian V Shenal; David W Harrison; Heath A Demaree
Journal:  Neuropsychol Rev       Date:  2003-03       Impact factor: 7.444

7.  Anxiety and depression in Parkinson's disease.

Authors:  Atbin Djamshidian; Joseph H Friedman
Journal:  Curr Treat Options Neurol       Date:  2014-04       Impact factor: 3.598

Review 8.  CBT for the treatment of depression in Parkinson's disease: a promising nonpharmacological approach.

Authors:  Roseanne DeFronzo Dobkin; Matthew Menza; Karina L Bienfait
Journal:  Expert Rev Neurother       Date:  2008-01       Impact factor: 4.618

9.  Mood Disorders in Neurologic Illness.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-03       Impact factor: 3.972

10.  Confirmatory factor analysis of the motor unified Parkinson's disease rating scale.

Authors:  Stefanie D Vassar; Yvette M Bordelon; Ron D Hays; Natalie Diaz; Rebecca Rausch; Cherry Mao; Barbara G Vickrey
Journal:  Parkinsons Dis       Date:  2012-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.